|
|
Vaccine Detail
|
Adenovirus Type 4 and Type 7 Vaccine, Live, Oral |
| Vaccine Information |
- Vaccine Name: Adenovirus Type 4 and Type 7 Vaccine, Live, Oral
- Target Pathogen: Adenovirus
- Target Disease: Respiratory infection
- Product Name: Adenovirus Type 4 and Type 7 Vaccine, Live, Oral
- Manufacturer: Barr Labs, Inc.
- Vaccine Ontology ID: VO_0000096
- CDC CVX code: 143
- Type: Live vaccine
- Status: Licensed
- Location Licensed: United States
- Host Species for Licensed Use: Human
- Preparation: Virus is prepared in human-diploid fibroblast cell cultures (strain WI-38). The virus strains have not been attenuated. The virus is harvested and dried. The dry virus material includes monosodium glutamate, sucrose, D-mannose, D-fructose, dextrose, human serum albumin, potassium phosphate and plasdone C (FDA: Adenovirus Vaccine).
- Immunization Route: orally
- Storage: Store refrigerated between 2° and 8° C (35° and 46° F). Do not freeze (FDA: Adenovirus Vaccine).
- Approved Age for Licensed Use: Approved for use in military populations 17-50 years of age (FDA: Adenovirus Vaccine).
- Contraindication: Pregnancy, allergy to vaccine components, or inability to swallow tablets whole (FDA: Adenovirus Vaccine).
- Description: Indicated for active immunization for the prevention of febrile acute respiratory disease caused by Adenovirus Type 4 and Type 7, virus strains have not been attenuated. The vaccine is composed of two tablets (one of Adenovirus type 4 and one Adenovirus type 7) designed to pass intact through the stomach and release the live virus in the intestine (FDA: Adenovirus Vaccine).
|
| Host Response |
|
|
| References |
FDA: Adenovirus Vaccine: FDA: Adenovirus Vaccine [http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm247508.htm]
|
|
